Novo Nordisk A/S ADR (NVO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2014 | 06-2014 | 03-2014 | 12-2013 | 09-2013 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 2,154,512 | 919,184 | 484,968 | 1,910,657 | 1,674,413 |
| Marketable Securities | 271,272 | 319,444 | 637,439 | 937,162 | 929,736 |
| Receivables | 2,893,924 | 3,083,613 | 3,324,419 | 2,941,500 | 3,002,150 |
| Inventories | 2,008,730 | 1,966,476 | 1,891,926 | 1,701,211 | 1,658,784 |
| TOTAL | $7,328,438 | $6,288,717 | $6,338,752 | $7,490,530 | $7,265,083 |
| Non-Current Assets | |||||
| PPE Net | 4,024,936 | 4,074,479 | 4,023,948 | 3,897,184 | 3,884,112 |
| Investments And Advances | 146,850 | 141,710 | 137,591 | 98,133 | 36,230 |
| Intangibles | 248,844 | 314,114 | 309,351 | 287,632 | 298,723 |
| Other Non-Current Assets | 939,306 | 885,548 | 807,729 | 753,541 | 616,450 |
| TOTAL | $5,359,936 | $5,415,851 | $5,278,619 | $5,036,490 | $4,835,516 |
| Total Assets | $12,688,370 | $11,704,570 | $11,617,370 | $12,527,020 | $12,100,600 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 50,552 | 74,623 | 147,695 | 38,292 | 118,992 |
| Accounts payable and accrued liabilities | 531,864 | 549,194 | 641,113 | 728,785 | 520,546 |
| Other current liabilities | 4,199,554 | 3,462,976 | 3,599,602 | 3,151,658 | 3,037,315 |
| TOTAL | $5,345,518 | $4,364,882 | $4,849,129 | $4,314,473 | $4,557,039 |
| Non-Current Liabilities | |||||
| aiOther Non-Current Liabilities | 583,128 | 520,154 | 504,073 | 511,325 | 515,395 |
| TOTAL | $584,730 | $601,394 | $599,046 | $631,008 | $594,960 |
| Total Liabilities | $5,930,248 | $4,966,276 | $5,448,175 | $4,945,481 | $5,151,999 |
| Shareholders' Equity | |||||
| Common Shares | 94,340 | 97,414 | 101,035 | 97,955 | 97,680 |
| Retained earnings | 6,896,254 | 6,636,099 | 5,945,451 | 7,326,500 | 6,716,477 |
| Other shareholders' equity | -230,468 | 5,779 | 126,711 | 161,084 | 137,443 |
| TOTAL | $6,758,126 | $6,738,292 | $6,169,197 | $7,581,539 | $6,948,600 |
| Total Liabilities And Equity | $12,688,374 | $11,704,568 | $11,617,372 | $12,527,020 | $12,100,599 |